MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajcp/aqaf077

Медицинская библиотека · American journal of clinical pathology · 2025

BinaxNOW vs malaria: A diagnostic showdown: Design and implementation of a verification strategy across 4 academic hospitals in an area with low malaria prevalence.

Turbett Sarah E, Bielawski Derek, Dighe Anand S, Kaseta Nancy, Lewandrowski Kent, Mercer Lynn, Patten Constance, Sta Cruz Maria Lilia, Shenoy Erica S, Branda John A

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Due to low malaria prevalence, implementation of the only US Food and Drug Administration (FDA)-cleared rapid malaria diagnostic, BinaxNOW Malaria, in US clinical laboratories is challenging due to limited clinical specimens for test verification. We describe the initial BinaxNOW evaluation at an academic medical center and its verification across a large health care network with site-based microbiology laboratories, using well-characterized, previously tested blood samples.

METHODS

For the initial evaluation, we compared the BinaxNOW Malaria to blood smear examination in 294 whole-blood specimens at the primary evaluation site. For subsequent site-based verification, each site tested 10 previously malaria antigen-positive and 10 previously malaria antigen-negative whole-blood specimens. Positive percent agreement (PPA), negative percent agreement (NPA), concordance, and reproducibility were calculated.

RESULTS

For the initial evaluation, the BinaxNOW Malaria correctly identified Plasmodium species in 100% of specimens positive for Plasmodium falciparum with 96% identified to the species level. Overall BinaxNOW Malaria test sensitivity and specificity were 100%. For the subsequent site-based verification, PPA, NPA, concordance, and reproducibility were 100%.

CONCLUSIONS

The approach described provides proof of concept for BinaxNOW Malaria test verification in areas with low malaria prevalence using archived well-characterized blood samples. With this strategy, rapid malaria antigen testing could be expanded, improving diagnostic capabilities across the United States.

Для цитирования: Turbett Sarah E, Bielawski Derek, Dighe Anand S, Kaseta Nancy, Lewandrowski Kent, Mercer Lynn, Patten Constance, Sta Cruz Maria Lilia, Shenoy Erica S, Branda John A. BinaxNOW vs malaria: A diagnostic showdown: Design and implementation of a verification strategy across 4 academic hospitals in an area with low malaria prevalence.. American journal of clinical pathology. 2025. DOI: 10.1093/ajcp/aqaf077.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.